77/100BCRH Public stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for CRH Public is 126.86, 35.5% above the current price of 93.61. Their targets range from 106.00 to 165.60.
Of the 11 firms that rated CRH Public in the past 12 months, 11 rate it buy or strong buy, 0 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 106.00 to 165.60, with an average of 126.86.
| Buy | 11 | |
| Hold | 0 | |
| Sell | 0 |
12-month price target
| Highest target | 165.60 |
| Average target | 126.86 |
| Lowest target | 106.00 |
| Current price | 93.61 |
CRH Public price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their CRH Public price target and rating?
How analysts rate CRH Public, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
11 of 11 firms rate it buy now, against 8 of 9 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
CRH Public analyst upgrades, downgrades and price targets
The latest rating change came on 15 April 2026, when Wells Fargo upgraded CRH Public from Equal Weight to Overweight. The most recent new target came from Truist Financial on 2 November 2026: 120.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 2 Nov 2026 | Truist Financial Keith Hughes | — | 105.00 → 120.00 | +14.3% | 96.58 |
| 2 Nov 2026 | D.A. Davidson Garik Shmois | — | 137.00 → 114.00 | -16.8% | 96.87 |
| 19 Oct 2026 | Barclays | Reiterated · Overweight | 131.00 → 110.00 | -16.0% | 83.63 |
| 9 Oct 2026 | Deutsche Bank | — | 139.00 → 118.00 | -15.1% | 81.56 |
| 9 Oct 2026 | RBC Capital | Reiterated · Outperform | 135.00 | — | 82.00 |
| 5 Oct 2026 | Truist Financial | Reiterated · Buy | 105.00 | — | 81.94 |
| 5 Oct 2026 | Wells Fargo | Reiterated · Overweight | 107.00 → 106.00 | -0.9% | 81.94 |
| 22 Sept 2026 | UBS | Reiterated · Buy | 147.00 → 135.00 | -8.2% | 88.01 |
| 9 Sept 2026 | Wells Fargo | Reiterated · Overweight | 132.00 → 107.00 | -18.9% | 90.61 |
| 8 Sept 2026 | Berenberg Bank Harry Goad | — | 140.00 | — | 92.25 |
| 24 Aug 2026 | D.A. Davidson Garik Shmois | — | 120.00 → 137.00 | +14.2% | 95.79 |
| 31 Jul 2026 | Stephens | Reiterated · Overweight | 125.00 | — | 96.00 |
| 8 Jul 2026 | Wells Fargo | Reiterated · Overweight | 133.00 → 132.00 | -0.8% | 106.21 |
| 26 Jun 2026 | Jefferies | Reiterated · Buy | 165.60 | — | 113.05 |
| 15 Apr 2026 | Morgan Stanley Angel Castillo | — | 140.00 → 139.00 | -0.7% | 116.19 |
| 15 Apr 2026 | Wells Fargo | Upgraded · Equal Weight → Overweight | — | — | — |
| 20 Feb 2026 | D.A. Davidson | — | 120.00 | — | 125.17 |
| 29 Jan 2026 | Wells Fargo | Reiterated · Equal Weight | 138.00 → 133.00 | -3.6% | 122.46 |
| 13 Jan 2026 | Wells Fargo | Downgraded · Overweight → Equal Weight | 135.00 → 138.00 | +2.2% | 131.38 |
| 8 Jan 2026 | UBS | Reiterated · Buy | 138.00 → 147.00 | +6.5% | 122.77 |
| 10 Dec 2025 | Morgan Stanley Angel Castillo | Reiterated · Overweight | 134.00 → 140.00 | +4.5% | 123.68 |
| 8 Dec 2025 | Deutsche Bank | — | 139.00 | — | 119.49 |
CRH Public EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Revenue
EPS
Does CRH Public beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 33.6% off the result, either way, and their revenue estimate 2.8%, over the last 12 quarters.
- EPS beats
- 12 / 21
- Revenue beats
- 11 / 20
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +13.3%
- Since
- March 1995
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 29 Oct 2026 | 2.06 | 2.09 | +1.5% | 11.56B | 11.40B | -1.4% |
| Q2 FY2026 | 30 Jul 2026 | 2.02 | 2.21 | +9.4% | 10.68B | 10.78B | +0.9% |
| Q1 FY2026 | 30 Apr 2026 | -0.22 | -0.27 | -23.5% | 7.07B | 7.37B | +4.3% |
| Q4 FY2025 | 18 Feb 2026 | 1.52 | 1.52 | 0.0% | 9.50B | 9.42B | -0.9% |
| Q3 FY2025 | 5 Nov 2025 | 2.20 | 2.23 | +1.4% | 11.14B | 11.07B | -0.6% |
| Q2 FY2025 | 6 Aug 2025 | 1.94 | 1.94 | 0.0% | 10.15B | 10.21B | +0.5% |
| Q1 FY2025 | 5 May 2025 | -0.08 | -0.14 | -76.8% | 6.76B | 6.24B | -7.7% |
| Q4 FY2024 | 26 Feb 2025 | 1.44 | 1.45 | +0.7% | 9.00B | 8.87B | -1.4% |
| Q3 FY2024 | 7 Nov 2024 | 2.10 | 1.97 | -6.2% | 10.53B | 10.52B | -0.1% |
| Q3 FY2024 | 7 Nov 2024 | 2.10 | 1.77 | -15.7% | 10.53B | 9.41B | -10.6% |
| Q1 FY2024 | 10 May 2024 | -0.10 | 0.15 | +258.2% | 6.39B | 6.08B | -4.8% |
| Q4 FY2023 | 29 Feb 2024 | 2.79 | 3.08 | +10.4% | 18.79B | 18.81B | +0.1% |
CRH Public stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If CRH Public's earnings keep growing at the 7.8% a year analysts expect to FY2028, it would earn about 8.09 a share in FY2030. At the P/E it has traded at over the last five years (7.8 to 22.5) that is 63.46 to 182.15 a share, or 132.93 at its average P/E of 16.4. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 5.40 | 42.42 | 88.85 | 121.76 |
| FY2027 | 6.07 | 47.64 | 99.80 | 136.76 |
| FY2028 | 6.96 | 54.60 | 114.37 | 156.72 |
| FY2029 (extrapolated) | 7.50 | 58.86 | 123.30 | 168.96 |
| FY2030 (extrapolated) | 8.09 | 63.46 | 132.93 | 182.15 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 7.8% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (7.8, 16.4, 22.5).
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 235.690 | 464.49205Price 235.69627 | +97.1% | |
| 28.860 | 56.2634Price 28.8696 | +94.9% | |
| 199.110 | 384.58163Price 199.112,644 | +93.1% | |
| 123.990 | 237.24178Price 123.99297 | +91.3% | |
| 157.820 | 297.58169Price 157.82471 | +88.6% | |
| 162.670 | 305.52160Price 162.67396 | +87.8% | |
| 216.610 | 405.38304Price 216.61507 | +87.1% |
Furthest below the fair value on each stock's page, updated every day.